Journal article

Phase IB Study of Vemurafenib in Combination with the Mek Inhibitor, GDC-0973, in Patients (PTS) with Unresectable or Metastatic BRAFV600 Mutated Melanoma (BRIM7)

R Gonzalez, A Ribas, A Daud, A Pavlick, TF Gajewski, I Puzanov, MSL Teng, I Chan, NW Choong, G McArthur

Annals of Oncology | Elsevier BV | Published : 2012

University of Melbourne Researchers

Citation metrics